Literature DB >> 6295430

Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection.

G R Skinner, A Buchan, D Williams, J Marsden, C Hartley, G Wilbanks, M Turyk, E S Namkoong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6295430      PMCID： PMC2040654     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  18 in total

1.  Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2.

Authors:  M A Walz; R W Price; K Hayashi; B J Katz; A L Notkins
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

2.  Serological relatedness of herpes simplex viruses. Type-specificity of antibody response.

Authors:  G R Skinner; M E Thouless; S Trueman; J Edwards; A J Gibbs
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

3.  Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a "hit and run" mechanism.

Authors:  G R Skinner
Journal:  Br J Exp Pathol       Date:  1976-08

4.  Immunogenic properties of formalin herpes antigen prepared from cell cultures.

Authors:  R Benda; V Dbalý
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1973

5.  Experimental human reinfection with herpes simplex virus.

Authors:  H Blank; H G Haines
Journal:  J Invest Dermatol       Date:  1973-10       Impact factor: 8.551

6.  The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.

Authors:  C Sim; D H Watson
Journal:  J Gen Virol       Date:  1973-05       Impact factor: 3.891

7.  Precipitating antibodies to herpes simplex virus in human sera: prevalence of antibody to common antigen (band II).

Authors:  G R Skinner; J Taylor; J Edwards
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

8.  Cytology and histopathology of cervical herpes simplex infection.

Authors:  Z M Naib; A J Nahmias; W E Josey
Journal:  Cancer       Date:  1966-07       Impact factor: 6.860

9.  Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology: evidence towards pre-pubertal vaccination of sero-negative female subjects.

Authors:  G R Skinner; J E Whitney; C Hartley
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

10.  Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice.

Authors:  R R McKendall
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441
View more
  2 in total

1.  Antibody reactivity with Skinner HSV vaccine.

Authors:  E M Muniu; J Durham; D Shariff; C E Hartley; A Fuller; J Melling; C Wiblin; G Wilkins; A Buchan; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

2.  Follow-up report on 50 subjects vaccinated against herpes genitalis with Skinner vaccine.

Authors:  G R Skinner; C G Fink; M Cowan; A Buchan; A Fuller; C E Hartley; J Durham; C Wiblin; J Melling
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.